Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas

Author:

Paolino Giovanni12ORCID,Didona Dario3ORCID,Scarnò Marco4,Tallarico Mariagrazia1,Cantoresi Franca1,Calvieri Stefano1,Mercuri Santo Raffaele2,Piccolo Domenico5,Bottoni Ugo6,Kyriakou Aikaterini1,Cantisani Carmen1ORCID

Affiliation:

1. Dermatology ClinicLa Sapienza‐Università di Roma Rome Italy

2. Dermatology and Cosmetology UnitSan Raffaele Hospital Milan Italy

3. Klinik für Dermatologie und AllergologieUniversitätsklinikum Marburg Marburg Germany

4. Super Computing Applications and Innovation (SCAI)CINECA Rome Italy

5. Italian Association Outpatient Dermatologists Pescara Italy

6. Dermatology ClinicUniversity Magna Grecia Catanzaro Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Reference7 articles.

1. Nonmelanoma skin cancer: Is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data;Bivens M. M.;Dermatologic Surgery,2006

2. Imiquimod 5% Cream Use in Dermatology, Side Effects and Recent Patents

3. Non-Melanocytic Skin Cancers of the Head and Neck: A Clinical Study in Jeju Province

4. Topical pharmacotherapy for skin cancer: Part II. Clinical applications;Micali G.;Journal of American Academy of Dermatology,2014

5. Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3